Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Investigator: Jorge Darcourt, MD

Study Coordinator: Pej Hemati

Status: Enrolling

ClinicalTrials.gov Number: NCT03574571

Phone: 713.441.3926

Protocol Number: Pro00022762

Description

The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone.
More to Explore
Live Chat Available